<DOC>
	<DOCNO>NCT00002806</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining radiation therapy chemotherapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness procarbazine , lomustine , vincristine follow radiation therapy treat adult supratentorial glioma .</brief_summary>
	<brief_title>Chemotherapy Followed Radiation Therapy Treating Adults With Supratentorial Glioma</brief_title>
	<detailed_description>OBJECTIVES : I . Estimate response rate patient newly diagnose supratentorial low-grade glioma follow neoadjuvant chemotherapy PCV ( procarbazine/lomustine/vincristine ) . II . Describe toxicity PCV . III . Determine incidence disease progression patient PCV treatment . OUTLINE : The follow acronym use : CCNU Lomustine , NSC-79037 PCB Procarbazine , NSC-77213 PCV PCB/CCNU/VCR VCR Vincristine , NSC-67574 3-Drug Combination Chemotherapy Followed Radiotherapy . PCV ; follow external-beam cranial irradiation use least 6 MV photon .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Procarbazine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Lomustine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm supratentorial * grade I/II glioma , include : Diffuse fibrillary astrocytoma No pilocytic astrocytoma No mixed tumor ependymoma element * Supratentorial site include : Frontal , temporal , parietal , occipital lobe Thalamus , basal ganglion , midbrain Lateral third ventricle Pons , medulla , optic chiasm tumor allow secondary eligible tumor More 1 separate tumor allow Diagnosis base surgical biopsy subtotal resection Measurable evaluable disease T2weighted MRI require PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Hematopoietic : WBC great 3,500/mm3 Platelet count great 130,000/mm3 Hemoglobin great 9 g/dL Hepatic : Bilirubin le 2 time upper limit normal ( ULN ) AST le 2 time ULN Alkaline phosphatase less 2 time ULN Renal : Creatinine le 1.5 time ULN Other : No active uncontrolled infection No second malignancy within 3 year except : Nonmelanomatous skin cancer In situ cervical cancer No pregnant nursing woman Negative pregnancy test require within 7 day prior entry Effective contraception require fertile patient PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : At least 1 week since prior steroid OR Stable steroid dose least 1 week prior study Radiotherapy : No prior cranial head neck irradiation Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>adult diffuse astrocytoma</keyword>
</DOC>